Suspected Agomelatine-induced restless legs syndrome: a case report

<h2>Background</h2> <p>Restless Legs Syndrome (RLS) is a sensorimotor disorder characterized by unpleasant and distressing sensations in the lower limbs that are more pronounced in the evening, commence or worsen at rest, and show partial or complete relief following movement. It c...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
المؤلف الرئيسي: Mustafa Abdul Karim (14159016) (author)
مؤلفون آخرون: Nadeen Al-Baz (14153124) (author), Sami Ouanes (9617363) (author), Majid Alabdulla (12051430) (author), Peter M. Haddad (14153136) (author)
منشور في: 2022
الموضوعات:
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
_version_ 1864513566623662080
author Mustafa Abdul Karim (14159016)
author2 Nadeen Al-Baz (14153124)
Sami Ouanes (9617363)
Majid Alabdulla (12051430)
Peter M. Haddad (14153136)
author2_role author
author
author
author
author_facet Mustafa Abdul Karim (14159016)
Nadeen Al-Baz (14153124)
Sami Ouanes (9617363)
Majid Alabdulla (12051430)
Peter M. Haddad (14153136)
author_role author
dc.creator.none.fl_str_mv Mustafa Abdul Karim (14159016)
Nadeen Al-Baz (14153124)
Sami Ouanes (9617363)
Majid Alabdulla (12051430)
Peter M. Haddad (14153136)
dc.date.none.fl_str_mv 2022-11-22T21:17:45Z
dc.identifier.none.fl_str_mv 10.1186/s12888-021-03175-5
dc.relation.none.fl_str_mv https://figshare.com/articles/journal_contribution/Suspected_Agomelatine-induced_restless_legs_syndrome_a_case_report/21598335
dc.rights.none.fl_str_mv CC BY 4.0
info:eu-repo/semantics/openAccess
dc.subject.none.fl_str_mv Clinical sciences
Psychiatry and Mental health
dc.title.none.fl_str_mv Suspected Agomelatine-induced restless legs syndrome: a case report
dc.type.none.fl_str_mv Text
Journal contribution
info:eu-repo/semantics/publishedVersion
text
contribution to journal
description <h2>Background</h2> <p>Restless Legs Syndrome (RLS) is a sensorimotor disorder characterized by unpleasant and distressing sensations in the lower limbs that are more pronounced in the evening, commence or worsen at rest, and show partial or complete relief following movement. It can occur as a primary disorder, secondary to medical conditions or treatment with medications including but not limited to antidepressants or antipsychotics.</p> <h2>Case presentation</h2> <p>A 32-year old man with major depressive disorder showed partial response to Escitalopram 10 mg daily. Agomelatine 25 mg at night was added to Escitalopram to treat his residual depressive symptoms, namely insomnia and tiredness. Within two days he developed restlessness and unpleasant sensations in his legs which were worse at night. Symptom severity increased over the following days, prompting an urgent consultation a week later. The patient’s presentation met the criteria for RLS. Agomelatine was discontinued leaving the patient on Escitalopram alone. The patient’s symptoms improved within 24 h of stopping Agomelatine, with complete resolution four days later. There was no recurrence of RLS during follow-up. The patient scored 6 on Naranjo’s adverse drug reaction probability scale, indicating a probable adverse drug reaction caused by Agomelatine.</p> <h2>Conclusions</h2> <p>To the best of our knowledge, this is the first case report of suspected Agomelatine-induced RLS. Clinicians need to be aware of RLS to enable prompt diagnosis and management. We suggest adding Agomelatine to the list of agents that can potentially induce RLS.</p><h2>Other Information</h2> <p> Published in: BMC Psychiatry<br> License: <a href="http://creativecommons.org/licenses/by/4.0/" target="_blank">http://creativecommons.org/licenses/by/4.0/</a><br>See article on publisher's website: <a href="http://dx.doi.org/10.1186/s12888-021-03175-5" target="_blank">http://dx.doi.org/10.1186/s12888-021-03175-5</a></p>
eu_rights_str_mv openAccess
id Manara2_24a9cf4be1255cbd8ed3a5aea16084b7
identifier_str_mv 10.1186/s12888-021-03175-5
network_acronym_str Manara2
network_name_str Manara2
oai_identifier_str oai:figshare.com:article/21598335
publishDate 2022
repository.mail.fl_str_mv
repository.name.fl_str_mv
repository_id_str
rights_invalid_str_mv CC BY 4.0
spelling Suspected Agomelatine-induced restless legs syndrome: a case reportMustafa Abdul Karim (14159016)Nadeen Al-Baz (14153124)Sami Ouanes (9617363)Majid Alabdulla (12051430)Peter M. Haddad (14153136)Clinical sciencesPsychiatry and Mental health<h2>Background</h2> <p>Restless Legs Syndrome (RLS) is a sensorimotor disorder characterized by unpleasant and distressing sensations in the lower limbs that are more pronounced in the evening, commence or worsen at rest, and show partial or complete relief following movement. It can occur as a primary disorder, secondary to medical conditions or treatment with medications including but not limited to antidepressants or antipsychotics.</p> <h2>Case presentation</h2> <p>A 32-year old man with major depressive disorder showed partial response to Escitalopram 10 mg daily. Agomelatine 25 mg at night was added to Escitalopram to treat his residual depressive symptoms, namely insomnia and tiredness. Within two days he developed restlessness and unpleasant sensations in his legs which were worse at night. Symptom severity increased over the following days, prompting an urgent consultation a week later. The patient’s presentation met the criteria for RLS. Agomelatine was discontinued leaving the patient on Escitalopram alone. The patient’s symptoms improved within 24 h of stopping Agomelatine, with complete resolution four days later. There was no recurrence of RLS during follow-up. The patient scored 6 on Naranjo’s adverse drug reaction probability scale, indicating a probable adverse drug reaction caused by Agomelatine.</p> <h2>Conclusions</h2> <p>To the best of our knowledge, this is the first case report of suspected Agomelatine-induced RLS. Clinicians need to be aware of RLS to enable prompt diagnosis and management. We suggest adding Agomelatine to the list of agents that can potentially induce RLS.</p><h2>Other Information</h2> <p> Published in: BMC Psychiatry<br> License: <a href="http://creativecommons.org/licenses/by/4.0/" target="_blank">http://creativecommons.org/licenses/by/4.0/</a><br>See article on publisher's website: <a href="http://dx.doi.org/10.1186/s12888-021-03175-5" target="_blank">http://dx.doi.org/10.1186/s12888-021-03175-5</a></p>2022-11-22T21:17:45ZTextJournal contributioninfo:eu-repo/semantics/publishedVersiontextcontribution to journal10.1186/s12888-021-03175-5https://figshare.com/articles/journal_contribution/Suspected_Agomelatine-induced_restless_legs_syndrome_a_case_report/21598335CC BY 4.0info:eu-repo/semantics/openAccessoai:figshare.com:article/215983352022-11-22T21:17:45Z
spellingShingle Suspected Agomelatine-induced restless legs syndrome: a case report
Mustafa Abdul Karim (14159016)
Clinical sciences
Psychiatry and Mental health
status_str publishedVersion
title Suspected Agomelatine-induced restless legs syndrome: a case report
title_full Suspected Agomelatine-induced restless legs syndrome: a case report
title_fullStr Suspected Agomelatine-induced restless legs syndrome: a case report
title_full_unstemmed Suspected Agomelatine-induced restless legs syndrome: a case report
title_short Suspected Agomelatine-induced restless legs syndrome: a case report
title_sort Suspected Agomelatine-induced restless legs syndrome: a case report
topic Clinical sciences
Psychiatry and Mental health